| The role of TRAIL in apoptosis and immunosurveillance in cancer JM Pimentel, JY Zhou, GS Wu Cancers 15 (10), 2752, 2023 | 29 | 2023 |
| Targeting PP2A inhibits the growth of triple-negative breast cancer cells MH Uddin, JM Pimentel, M Chatterjee, JE Allen, Z Zhuang, GS Wu Cell Cycle 19 (5), 592-600, 2020 | 15 | 2020 |
| Regulation of programmed death ligand 1 (PD‐L1) expression by TNF‐related apoptosis‐inducing ligand (TRAIL) in triple‐negative breast cancer cells JM Pimentel, JY Zhou, GS Wu Molecular Carcinogenesis 62 (2), 135-144, 2023 | 7 | 2023 |
| Proteomic analysis identifies p62/SQSTM1 as a critical player in PARP inhibitor resistance MH Uddin, JY Zhou, J Pimentel, SM Patrick, S Kim, MP Shekhar, GS Wu Frontiers in oncology 12, 908603, 2022 | 3 | 2022 |
| Regulation of PD-L1 expression by TRAIL in triple-negative breast cancer cells JM Pimentel, JY Zhou, GS Wu Molecular carcinogenesis 62 (2), 135, 2023 | | 2023 |
| Cover Image, Volume 62, Issue 2 JM Pimentel, JY Zhou, GS Wu Molecular Carcinogenesis 62 (2), i-i, 2023 | | 2023 |
| The role of the immune response and inflammatory pathways in TNF-related apoptosis-inducing ligand (TRAIL) resistance in triple-negative breast cancer cells JM Pimentel, JY Zhou, S Kim, K Gurdziel, GS Wu American Journal of Cancer Research 13 (10), 4678, 2023 | | 2023 |
| Metabolic reprogramming with β-alanine to overcome chemotherapy resistance in pancreatic cancer D Yakoub, ST Totiger, A Moran, S Suwal, J Pimentel, L O'Donell, J Walls, ... Cancer Research 79 (13_Supplement), 5264-5264, 2019 | | 2019 |
| Metabolic Reprogramming With beta-alanine to Overcome Chemotherapy Resistance in Pancreatic Cancer S Totiger, A Moran, S Suwal, J Pimentel, L O'Donnell, JD Walls, ... PANCREAS 47 (10), 1429-1429, 2018 | | 2018 |
| Characterizing and Detecting How Protein Fragments Pass Through the Intestinal Epithelial Layer With Emphasis on the Absorption of Collagen's Fragments JM Pimentel | | 2014 |
GS WuProfessor of Oncology, Wayne State UniversityVerified email at wayne.edu